Nonsteroidal anti-inflammatory drugs versus placebo for post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and meta-analysis
Carregando...
Citações na Scopus
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
GEORG THIEME VERLAG KG
Autor de Grupo de pesquisa
Citação
ENDOSCOPY INTERNATIONAL OPEN, v.7, n.4, p.E477-E486, 2019
Resumo
Background and study aims Endoscopic retrograde cholangiopancreatography (ERCP) is the primary therapeutic procedure for treatment of diseases that affect the biliary tree and pancreatic duct. While the therapeutic success rate of ERCP is high, the procedure can cause complications, such as acute pancreatitis (PEP), bleeding, and perforation. This meta-analysis aimed to assess the efficacy of nonsteroidal anti-inflammatory drugs (NSAIDs) in preventing PEP following (ERCP). Materials and methods We searched databases, such as MEDLINE, Embase, and Cochrane Central Library. Only randomized controlled trials (RCTs) that compared the efficacy of NSAIDs and placebo for the prevention of PEP were included. Outcomes assessed included incidence of PEP, severity of pancreatitis, route of administration, and type of NSAIDs. Results Twenty-one RCTs were considered eligible with a total of 6854 patients analyzed. Overall, 3427 patients used NSAIDs before ERCP and 3427 did not use the drugs (control group). In the end, 250 cases of acute pancreatitis post-ERCP were diagnosed in the NSAIDs group and 407 cases in the placebo group. Risk for PEP was lower in the NSAID group (risk difference (RD): -0.05; 95% confidence interval (CI): -0.07 to -0.03; number need to treat (NNT), 20; P<0.05). Use of NSAIDs effectively prevented mild pancreatitis compared with use of placebo (2.5% vs. 4.1%; 95% CI, -0.05 to -0.01; NNT, 33; P<0.05), but the information on moderate and severe PEP could not be completely elucidated. Only rectal administration reduced incidence of PEP (6.8% vs. 13 %; 95% CI, -0.10 to -0.04; NNT, 20; P<0.05). Furthermore, only diclofenac or indomethacin use was effective in preventing PEP. Conclusions Rectal administration of diclofenac and indomethacin significantly reduced risk of developing mild PEP. Further RCTs are needed to compare efficacy between NSAID administration pathways in prevention of PEP after ERCP.
Palavras-chave
Referências
- Bhatia V, 2011, J CLIN GASTROENTEROL, V45, P170, DOI 10.1097/MCG.0b013e3181eb600e
- BRUST R, 1977, GASTROINTEST ENDOSC, V24, P77, DOI 10.1016/S0016-5107(77)73457-1
- Chandrasekhara V, 2017, GASTROINTEST ENDOSC, V85, P32, DOI 10.1016/j.gie.2016.06.051
- Cheon YK, 2007, GASTROINTEST ENDOSC, V66, P1126, DOI 10.1016/j.gie.2007.04.012
- Choudhary A, 2011, GASTROINTEST ENDOSC, V73, P275, DOI 10.1016/j.gie.2010.10.039
- De Moura Eduardo T.H., 2016, Rev. gastroenterol. Perú, V36, P308
- Dobronte Z, 2014, WORLD J GASTROENTERO, V20, P10151, DOI 10.3748/wjg.v20.i29.10151
- Dumonceau JM, 2014, ENDOSCOPY, V46, P799, DOI 10.1055/s-0034-1377875
- Elmunzer BJ, 2012, NEW ENGL J MED, V366, P1414, DOI 10.1056/NEJMoa1111103
- Andrade-Davila VF, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0314-2
- Ferreira AD, 2015, ABCD-ARQ BRAS CIR DI, V28, P207, DOI 10.1590/S0102-67202015000300016
- Freeman ML, 2001, GASTROINTEST ENDOSC, V54, P425, DOI 10.1067/mge.2001.117550
- GUERRA M, 1967, J AMER MED ASSOC, V200, P552, DOI 10.1001/jama.200.6.552
- Hauser G, 2017, SURG ENDOSC, V31, P602, DOI 10.1007/s00464-016-5004-9
- Hosseini M, 2016, ARCH IRAN MED, V19, P538, DOI 0161908/AIM.004
- Hwang HJ, 2017, REV ESP ENFERM DIG, V109, P174, DOI 10.17235/reed.2017.4565/2016
- Ishiwatari H, 2016, DIGEST DIS SCI, V61, P3292, DOI 10.1007/s10620-016-4251-x
- Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4
- Khoshbaten M, 2008, J GASTROEN HEPATOL, V23, pE11, DOI 10.1111/j.1440-1746.2007.05096.x
- Kubiliun NM, 2015, CLIN GASTROENTEROL H, V13, P1231, DOI 10.1016/j.cgh.2014.11.038
- Leerhoy B, 2016, SCAND J GASTROENTERO, V51, P1007, DOI 10.3109/00365521.2016.1172338
- Levenick JM, 2016, GASTROENTEROLOGY, V150, P911, DOI 10.1053/j.gastro.2015.12.040
- Li X, 2014, WORLD J GASTROENTERO, V20, P12322, DOI 10.3748/wjg.v20.i34.12322
- Loza AM, 2007, REV ESP ENFERM DIG, V99, P330
- Lua GW, 2015, DIGEST DIS SCI, V60, P3118, DOI 10.1007/s10620-015-3609-9
- Makela A, 1997, SCAND J CLIN LAB INV, V57, P401, DOI 10.3109/00365519709084587
- Mansour-Ghanaei F, 2016, WORLD J GASTROENTERO, V22, P5114, DOI 10.3748/wjg.v22.i21.5114
- Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
- Murray B, 2003, GASTROENTEROLOGY, V124, P1786, DOI 10.1016/S0016-5085(03)00384-6
- Nesvaderani M, 2015, INT J SURG, V23, P68, DOI 10.1016/j.ijsu.2015.07.701
- OLAZABAL A, 1980, J LAB CLIN MED, V96, P570
- Onofrio FD, 2017, SURG ENDOSC, V31, P2317, DOI 10.1007/s00464-016-5234-x
- Otsuka T, 2012, J GASTROENTEROL, V47, P912, DOI 10.1007/s00535-012-0554-7
- Park SW, 2015, ENDOSCOPY, V47, P33, DOI 10.1055/s-0034-1390743
- Patai A, 2015, J CLIN GASTROENTEROL, V49, P429, DOI 10.1097/MCG.0000000000000168
- Sajid MS, 2015, WORLD J GASTRO ENDOS, V7, P1341, DOI 10.4253/wjge.v7.i19.1341
- Senol A, 2009, WORLD J GASTROENTERO, V15, P3999, DOI 10.3748/wjg.15.3999
- Shi N, 2015, TURK J GASTROENTEROL, V26, P236, DOI 10.5152/tjg.2015.6000
- Sun HL, 2014, SURG-J R COLL SURG E, V12, P141, DOI 10.1016/j.surge.2013.10.010
- Ucar R, 2016, TURK J MED SCI, V46, P1059, DOI 10.3906/sag-1502-104
- Vandervoort J, 2002, GASTROINTEST ENDOSC, V56, P652, DOI 10.1067/mge.2002.129086
- Yokoe M, 2015, J HEPATO-BIL-PAN SCI, V22, P405, DOI 10.1002/jhbp.259
- Zhao ZH, 2017, GASTROINTEST ENDOSC, V86, P519, DOI 10.1016/j.gie.2016.12.020